EACR-AACR-IACR Basic & Translational Research Conference 2024: How to Bring Basic Science Discoveries to the Clinic

The EACR and AACR are proud to announce the 2024 edition of their joint Basic and Translational Research Conference, organised in conjunction with the IACR. The forum will highlight the latest cutting-edge advances in the understanding of the genomics, epigenetics, and molecular pathways involved in the development of pre-cancerous and cancerous lesions, and in cancer response to therapy. The scientific programme blends basic and translational research from preclinical models to patients.

Topics include immunotherapy, cell-based therapies, novel/undruggable targets, drug combinations and resistance, the precancer genome, liquid biopsies, preclinical models, the tumour microenvironment, and epigenetics. The target audience is basic and translational scientists, experienced investigators and trainees at all levels with an interest in cancer development and treatment, and clinicians involved in the development of novel therapeutic approaches to treatment.

Save the date! Registration opens 17 July 2023 

Rene Bernards (Netherlands), Kelly Bolton (USA), Adrian Bracken (Ireland), Cathrin Brisken (Switzerland), Annette Byrne (Ireland), Myriam Chalabi (Netherlands), Hugues de Thé (France), Jerome Galon (France), Phil H. Jones (UK), Johanna Joyce (Switzerland), Walter Koch (Ireland), Scott Lowe (USA), Crystal L. Mackall (USA), Fatima Mechta-Grigoriou (France), Jarushka Naidoo (Ireland), Lorraine O’Driscoll (Ireland), Michel Sadelain (USA), Laura Soucek (Spain), Jean Soulier (France), Suzanne Topalian (USA), Celine Vallot (France), and Eric Vivier (France)